The acceptance to germline gene therapy increased during COVID-19 pandemic among Japanese medical students

J Obstet Gynaecol Res. 2022 Jun;48(6):1495-1496. doi: 10.1111/jog.15246. Epub 2022 Mar 29.

Authors

Akifumi Ijuin^{1

2}, Tomonari Hayama^{1

3}, Hideya Sakakibara³

Affiliations

¹ Center for Reproductive Medicine, Yokohama City University Medical Center, Yokohama-shi, Japan.
² Department of Obstetrics and Gynecology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
³ Department of Gynecology, Yokohama City University Medical Center, Yokohama-shi, Japan.

No abstract available

Publication types

Letter

MeSH terms

COVID-19* / therapy
Genetic Therapy
Germ Cells
Humans
Japan
Pandemics
Students, Medical*